Marker Therapeutics (MRKR) Non-Current Debt (2013 - 2015)
Marker Therapeutics (MRKR) posted quarterly Non-Current Debt of $30000.0 for Q4 2015, down 43.33% year-over-year from $52942.0 in Q4 2014, and down 43.33% quarter-over-quarter from $52942.0 in Q3 2015.
Marker Therapeutics (MRKR) Non-Current Debt (2013 - 2015) Analysis & Trends
Marker Therapeutics (MRKR) has reported Non-Current Debt for 3 consecutive years, with $30000.0 the latest figure, recorded in Q4 2015.
- In Q4 2015, Non-Current Debt fell 43.33% year-over-year to $30000.0; the TTM figure through Dec 2015 stood at $30000.0 (down 43.33% YoY), while the FY2015 annual figure was $30000.0, down 43.33% from the prior year.
- Non-Current Debt eased to $30000.0 in Q4 2015 per MRKR's latest filing, from $52942.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $369000.0 in Q4 2013 and bottomed at $23000.0 in Q2 2015.
- Historically, Non-Current Debt has averaged $96804.3 across 3 years, with a median of $52942.0 in 2014.
- Annual changes were most pronounced in 2014 — Non-Current Debt slumped 85.65% — and 2015, when it sank 43.33%.
- Marker Therapeutics' Non-Current Debt stood at $369000.0 in 2013, then plunged by 85.65% to $52942.0 in 2014, then plunged by 43.33% to $30000.0 in 2015.
- Business Quant data shows MRKR's Non-Current Debt at $30000.0 in Q4 2015, $52942.0 in Q3 2015, and $23000.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | 8.96 Bn |
| 10 | Marker Therapeutics | 26.85 Mn | 14.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 30,000.00 |
| Sep 30, 2015 | 52,942.00 |
| Jun 30, 2015 | 23,000.00 |
| Mar 31, 2015 | 52,942.00 |
| Dec 31, 2014 | 52,942.00 |
| Dec 31, 2013 | 369,000.00 |